AzTrials
AzTrials

Varicose Veins of Lower LimbRRT CVDNCT03035747

Ongoing Registry of Treatment of Chronic Venous Diseases

An observational study of Varicose Veins of Lower Limb, run by Medalp Private Surgery Clinic at 1 site in Russia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Ongoing registration of patients with varicose veins disease treated by means of conventional surgery, endovenous thermal ablations, sclerotherapy, non-tumescent non-thermal methods Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Varicose Veins of Lower Limb
What is being tested?
conventional surgery, endovenous laser ablation and sclerotherapy
Type of treatment
Surgery or procedure
How many people
5,000 participants
Where
1 siteRussia
Study dates
Jul 2016to Jul 2036
How long will I take part?
12 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients undergoing interventions in cases varicose vein disease

Who may be able to join

  • Varicose veins with any source of pathological reflux, C2 - C6 according to the CEAP classification

Who cannot join

  • no exclusion criteria

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Evgeny Ilyukhin, MD, PhD contact

+79218451722

evgeny@ilyukhin.info

Russia1 site, 1 recruiting
  • Medalp private surgery clinic

    Saint Petersburg, 197758

    Oleg Shonov, MD, shonov.o@gmail.com

    Recruiting

Other trials in Russia

About this study

Official title: Russian Registry of Treatment of Chronic Venous Diseases

Ongoing registration of patients with varicose veins disease treated by means of conventional surgery, endovenous thermal ablations, sclerotherapy, non-tumescent non-thermal methods

Read the detailed description

Data of patients treated in different Russian medical centers are entered in a prospective digital database, and continuously updated.

There is planned to conduct prospective randomized, cohort and observational studies on the site of register

Being tested
conventional surgery, endovenous laser ablation, sclerotherapy, endovenous radiofrequency ablation, phlebectomy
Keywords
registry, varicose veins, conventional surgery, thermal ablation, radiofrequency, laser, sclerotherapy
Medical subject headings
Varicose Veins

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • conventional surgeryProcedure or surgery

    high ligation and stripping of incompetent saphenous veins

  • endovenous laser ablationProcedure or surgery

    endovenous laser ablation of incompetent saphenous veins

  • sclerotherapyProcedure or surgery

    ultrasound guided or catheter or or any other methods sclerotherapy of incompetent saphenous or varicose veins

  • endovenous radiofrequency ablationProcedure or surgery

    endovenous radiofrequency ablation of incompetent saphenous veins

  • phlebectomyProcedure or surgery

    hooks phlebectomy of varicose veins

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in patency target veins assessed by duplex ultrasonography in different follow up periods after conventional surgery, endovenous thermal ablations, sclerotherapy or non-tumescent non-thermal methods

    Measured: Baseline, 3 - 6, 12 months post-intervention

Secondary outcomes (3)
  1. Change in Quality of Life (QoL), assessed by Short form (SF)-36 health survey (optional)

    The SF-36 is a generic QoL questionnaire.

    Measured: Baseline, 3 and 12 months post-intervention

  2. Change in Venous Clinical Severity Score (VCSS) (optional)

    The VCSS is a validated scoring system for assessing signs, symptoms and complaints of venous disease.

    Measured: Baseline, 3 and 12 months post-intervention

  3. Change in Quality of Life (QoL), assessed by Aberdeen Varicose Vein Questionnaire (AVVQ) (optional)

    The AVVQ is a disease-specific QoL questionnaire aimed at venous disease.

    Measured: Baseline, 3 and 12 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2017 (estimated)
  2. Study startJul 2016
  3. Primary completionJul 2036 (estimated)
  4. Study completionJul 2036 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
5,000 participants (estimated)
Target duration
12 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT03035747
Sponsor's protocol ID
A001
Acronym
RRT CVD
Status last verified
Mar 2024
First submitted
25 Jan 2017
Last updated
13 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Varicose Veins of Lower Limb, run by Medalp Private Surgery Clinic at 1 site in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Evgeny Ilyukhin, MD, PhD (+79218451722, evgeny@ilyukhin.info), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in patency target veins assessed by duplex ultrasonography in different follow up periods after conventional surgery, endovenous thermal ablations, sclerotherapy or non-tumescent non-thermal methods (time frame: Baseline, 3 - 6, 12 months post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in